Indaptus Therapeutics, Inc. (INDP)

NASDAQ: INDP · Real-Time Price · USD

1.160

-0.010 (-0.85%)

At close: Sep 3, 2026, 4:00 PM EDT

1.160

0.00 (0.00%)

After-hours: Sep 3, 2026, 4:00 PM EDT

Indaptus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.55	8.51	5.79	13.36	9.63	39.13
Short-Term Investments	4	-	-	-	16.81	-
Cash & Short-Term Investments	11.55	8.51	5.79	13.36	26.43	39.13
Cash Growth	87.63%	47.02%	-56.69%	-49.45%	-32.45%	2289.75%
Other Receivables	-	-	-	-	-	0.02
Receivables	-	-	-	-	-	0.02
Prepaid Expenses	0.41	0.41	0.68	0.62	0.73	0.96
Other Current Assets	0.03	0.39	0.15	0.02	0.08	0.28
Total Current Assets	11.99	9.31	6.62	14	27.24	40.39
Property, Plant & Equipment	-	-	0.08	0.17	0.08	0.17
Other Long-Term Assets	-	-	0.64	0.75	0.74	0.02
Total Assets	11.99	9.31	7.34	14.92	28.06	40.58

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.51	0.54	0.87	0.81	1.38	2.54
Accrued Expenses	0.11	5.61	2.44	1.87	1.97	1.97
Current Portion of Leases	-	-	0.08	0.1	0.08	0.1
Total Current Liabilities	0.62	6.16	3.39	2.77	3.43	4.6
Long-Term Leases	-	-	-	0.07	-	0.07
Total Liabilities	0.62	6.16	3.39	2.85	3.43	4.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1.33	0.02	0	0.08	0.08	0.08
Additional Paid-In Capital	95.66	84.41	64.38	57.41	54.44	51.49
Retained Earnings	-85.62	-81.29	-60.44	-45.42	-29.99	-15.67
Comprehensive Income & Other	-	-	-	-	0.1	-
Total Common Equity	11.37	3.14	3.94	12.08	24.63	35.9
Shareholders' Equity	11.37	3.15	3.94	12.08	24.63	35.9
Total Liabilities & Equity	11.99	9.31	7.34	14.92	28.06	40.58

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	0.08	0.18	0.08	0.17
Net Cash (Debt)	11.55	8.51	5.7	13.19	26.35	38.96
Net Cash Growth	-	49.19%	-56.76%	-49.96%	-32.37%	2279.41%
Net Cash Per Share	0.35	8.81	17.07	43.95	89.31	266.70
Filing Date Shares Outstanding	133.24	2.24	0.52	0.3	0.3	0.29
Total Common Shares Outstanding	133.24	2.17	0.43	0.3	0.3	0.29
Working Capital	11.37	3.15	3.22	11.22	23.81	35.78
Book Value Per Share	0.09	1.45	9.19	40.25	82.09	121.71
Tangible Book Value	11.37	3.14	3.94	12.08	24.63	35.9
Tangible Book Value Per Share	0.09	1.45	9.19	40.25	82.09	121.71

SEC Filings: 10-K · 10-Q